A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

NCT05795699 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Fuchs Endothelial Corneal Dystrophy

Interventions

DRUG: Ripasudil
DRUG: Placebo

Sponsor

Kowa Research Institute, Inc.